Technology & Performance:

Unlike genomics or proteomics, metabolic phenotyping measures the real-time biochemical state of the organism, providing the closest readout of disease activity.

This enables earlier detection, higher sensitivity to change, and more actionable insights for therapy selection and monitoring.

Intellectual Property & Know-how:

The platform is built on proprietary methods spanning sample processing, high-resolution mass spectrometry workflows, quantitative normalization, and multi-omic data integration.

Critically, much of the defensibility lies in accumulated datasets, algorithms, and clinical correlations that are difficult to replicate.